American Century Companies’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Other funds holding NGNE
CC
RI
EC
BBA
TECP
American Century Companies's NGNE Position: Q2 2026 in Review
American Century Companies increased its Neurogene (NGNE) stake by 26% in Q2 2026, buying an estimated $132K and bringing the position to 23,330 shares worth $734K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.
American Century Companies first reported a position in NGNE in Q1 2024 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.
- American Century Companies held 23,330 shares of Neurogene worth $734K as of Q2 2026.
- American Century Companies bought 4,790 Neurogene shares in Q2 2026, an estimated $132K.
- Neurogene made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2494 holding.
- American Century Companies first reported a position in Neurogene in Q1 2024 and has held it in 5 quarters since.
- 102 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.